Wenchen Pu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Signaling Pathways in Disease
- Extracellular vesicles in disease
Papers in
-
- Signaling Pathways in Disease 8
- Protein Degradation and Inhibitors 5
- RNA modifications and cancer 5
- RNA Research and Splicing 4
- Co-authors
- Yong Peng (24 shared papers)Jiao Li (11 shared papers)Dan Sun (3 shared papers)Jin Wang (1 shared paper)Juan He (8 shared papers)Xuesha Liu (7 shared papers)Chun Wang (14 shared papers)Lunxu Liu (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)European Journal of Medicinal Chemistry (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Cancer Letters (2 papers)Molecular Cancer (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Wenchen Pu
40 papers receiving 1.7k citations
Wenchen Pu's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 756
- Molecular Biology 1.3k
- Oncology 154
- Immunology 114
- Molecular Medicine 26
Countries citing papers authored by Wenchen Pu
This map shows the geographic impact of Wenchen Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenchen Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenchen Pu more than expected).
Fields of papers citing papers by Wenchen Pu
This network shows the impact of papers produced by Wenchen Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenchen Pu. The network helps show where Wenchen Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenchen Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance Hit paper breakdown → | 2020 | 542 |
| 2 | 2018 | 122 | |
| 3 | 2018 | 116 | |
| 4 | 2022 | 88 | |
| 5 | 2018 | 80 | |
| 6 | 2018 | 79 | |
| 7 | 2018 | 70 | |
| 8 | 2017 | 65 | |
| 9 | 2018 | 47 | |
| 10 | 2018 | 41 | |
| 11 | 2014 | 41 | |
| 12 | 2017 | 39 | |
| 13 | 2024 | 37 | |
| 14 | 2019 | 36 | |
| 15 | 2020 | 31 | |
| 16 | 2017 | 30 | |
| 17 | 2018 | 21 | |
| 18 | 2019 | 21 | |
| 19 | 2019 | 21 | |
| 20 | 2019 | 19 |
About Wenchen Pu
Wenchen Pu is a scholar working on Molecular Biology, Organic Chemistry, Cancer Research, Oncology and Pharmacology, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (8 papers), Peptidase Inhibition and Analysis (7 papers), Cancer-related molecular mechanisms research (5 papers), Protein Degradation and Inhibitors (5 papers), RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers), MicroRNA in disease regulation (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Cancer Research (756 citations), Molecular Biology (1.3k citations), Oncology (154 citations), Immunology (114 citations) and Molecular Medicine (26 citations). Wenchen Pu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Yong Peng, Jiao Li, Dan Sun, Jin Wang, Juan He, Xuesha Liu, Chun Wang, Lunxu Liu, Jiankang Zhou and Yuanyuan Zheng. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Cancer Letters and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.